Advertisement
Singapore markets open in 3 hours 58 minutes
  • Straits Times Index

    3,322.62
    +14.72 (+0.45%)
     
  • S&P 500

    5,267.84
    -39.17 (-0.74%)
     
  • Dow

    39,065.26
    -605.78 (-1.53%)
     
  • Nasdaq

    16,736.03
    -65.51 (-0.39%)
     
  • Bitcoin USD

    67,768.27
    -1,646.27 (-2.37%)
     
  • CMC Crypto 200

    1,458.00
    -44.67 (-2.97%)
     
  • FTSE 100

    8,339.23
    -31.10 (-0.37%)
     
  • Gold

    2,329.80
    -63.10 (-2.64%)
     
  • Crude Oil

    76.91
    -0.66 (-0.85%)
     
  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     
  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     
  • Hang Seng

    18,868.71
    -326.89 (-1.70%)
     
  • FTSE Bursa Malaysia

    1,629.18
    +7.09 (+0.44%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,659.99
    +52.77 (+0.80%)
     

Investing in Bruker (BRKR)? Don't Miss Assessing Its International Revenue Trends

Have you evaluated the performance of Bruker's (BRKR) international operations for the quarter ending March 2024? Given the extensive global presence of this scientific equipment maker, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.

In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investors must understand a company's dependence on overseas markets, as this offers a window into the company's earnings stability, its ability to benefit from varied economic cycles and its potential for long-term growth.

Participation in global economies acts as a defense against economic difficulties at home and a pathway to more rapidly developing economies. However, it also comes with the complexities of dealing with fluctuating currencies, geopolitical risks and different market dynamics.

Our review of BRKR's last quarterly performance uncovered some notable trends in the revenue contributions from its international markets, which are commonly analyzed and tracked by Wall Street experts.

ADVERTISEMENT

The company's total revenue for the quarter stood at $721.7 million, increasing 5.3% year over year. Now, let's delve into BRKR's international revenue breakdown to gain insights into the significance of its operations beyond home turf.

Trends in BRKR's Revenue from International Markets

Rest of Europe accounted for 24.7% of the company's total revenue during the quarter, translating to $178.1 million. Revenues from this region represented a surprise of -2.28%, with Wall Street analysts collectively expecting $182.25 million. When compared to the preceding quarter and the same quarter in the previous year, Rest of Europe contributed $204.7 million (24%) and $159.8 million (23.3%) to the total revenue, respectively.

Of the total revenue, $66.8 million came from Germany during the last fiscal quarter, accounting for 9.3%. This represented a surprise of -13.68% as analysts had expected the region to contribute $77.39 million to the total revenue. In comparison, the region contributed $79.4 million, or 9.3%, and $62.6 million, or 9.1%, to total revenue in the previous and year-ago quarters, respectively.

Other International generated $59.4 million in revenues for the company in the last quarter, constituting 8.2% of the total. This represented a surprise of +27.5% compared to the $46.59 million projected by Wall Street analysts. Comparatively, in the previous quarter, Other International accounted for $61.9 million (7.2%), and in the year-ago quarter, it contributed $47.6 million (7%) to the total revenue.

Prospective Revenues in International Markets

Wall Street analysts expect Bruker to report $768.15 million in total revenue for the current fiscal quarter, indicating an increase of 12.7% from the year-ago quarter. Rest of Europe, Germany and Other International are expected to contribute 24.7% ($189.42 million), 10.3% ($79.18 million) and 5.7% ($44.04 million) to the total revenue, respectively.

Analysts expect the company to report a total annual revenue of $3.3 billion for the full year, marking an increase of 11.4% compared to last year. The expected revenue contributions from Rest of Europe, Germany and Other International are projected to be 25.9% ($856.65 million), 10.3% ($338.83 million) and 5.4% ($176.77 million) of the total revenue, in that order.

In Conclusion

Bruker's reliance on international markets for revenues offers both opportunities and risks. Hence, keeping an eye on its international revenue trends could significantly help forecast the company's prospects.

In an environment where global interconnections and geopolitical skirmishes are intensifying, Wall Street analysts keep a keen eye on these trends, particularly for firms with overseas operations, to adjust their earnings predictions. Moreover, a range of other aspects, including how a company fares in its home country, significantly affects these projections.

We at Zacks strongly focus on the dynamic earnings forecast of companies, given that empirical studies have demonstrated its potent impact on the immediate price movement of stocks. Invariably, there's a positive relationship -- upward earnings predictions often result in an increase in stock prices.

With an impressive externally audited track record, our proprietary stock rating tool - the Zacks Rank - harnesses the power of earnings estimate revisions and serves as an effective indicator of a stock's near-term price performance.

At the moment, Bruker has a Zacks Rank #3 (Hold), signifying that its performance may align with the overall market trend in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

A Review of Bruker's Recent Stock Market Performance

Over the past month, the stock has lost 13.6% versus the Zacks S&P 500 composite's 1.3% increase. The Zacks Computer and Technology sector, of which Bruker is a part, has risen 1.4% over the same period. The company's shares have declined 7.5% over the past three months compared to the S&P 500's 4.3% increase. Over the same period, the sector has risen 2.2%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Bruker Corporation (BRKR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research